AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Total Equity
AxoGen Inc
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AxoGen Inc
NASDAQ:AXGN
|
Total Equity
$93.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Equity
$25.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
17%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$19.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$19.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$38.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$14B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
See Also
What is AxoGen Inc's Total Equity?
Total Equity
93.2m
USD
Based on the financial report for Mar 31, 2024, AxoGen Inc's Total Equity amounts to 93.2m USD.
What is AxoGen Inc's Total Equity growth rate?
Total Equity CAGR 5Y
-8%
Over the last year, the Total Equity growth was -4%. The average annual Total Equity growth rates for AxoGen Inc have been -8% over the past three years , -8% over the past five years .